1. Search Result

Search Result

Results for "1627716-22-6" in MCE Product Catalog:

Cat. No. Product Name Target Research Area
  • HY-124596


    Epigenetic Reader Domain Cancer
    CD161 (NKR-P1A) is a potent, selective and orally bioavailable bromodomain and extra-terminal (BET) bromodomain inhibitor with an IC50s of 28.2 nM and 7.2 nM for BRD4 BD1 and BRD4 BD2, respectively. CD161 has good anticancer activity.